1 min read
Integrated BioPharma Posts $0.02 Q3 GAAP Loss Per Share
Revenue came to $9.91 million, down 21.9% year over year. The company swung to a $110,000 gross loss from $1.02 million in gross profit a year earlier.

Integrated BioPharma, Inc. (INBP) recorded a $0.02 GAAP loss per share for the third quarter as revenue fell 21.9% year over year to $9.91 million, alongside weaker gross and operating results.
Gross results moved to a loss of $110,000 from $1.02 million in gross profit in Q3 2025. Cost of sales in the latest quarter totaled $10.03 million.
The company recorded an operating loss of $960,000, compared with operating income of $160,000 in Q3 2025.